Report on a Patient with Watery Diarrhoea Syndrome Caused by a Pancreatic Tumour Containing Neurotensin, Enkephalin and Calcitonin
- 12 January 1980
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 208 (1-6) , 95-100
- https://doi.org/10.1111/j.0954-6820.1980.tb01159.x
Abstract
A patient with watery diarrhea syndrome (WDS) is described. A pancreatic tumor was found containing many cells with immunoreactivity to enkephalin and neurotensin, a few with immunoreactivity to calcitonin but none to vasoactive intestinal peptide (VIP). High levels of calcitonin, neurotensin, VIP and pancreatic polypeptide (PP) were present in plasma as measured by radioimmunossay. After removal of the tumor, the plasma levels of the first 3 peptides returned to normal and the WDS disappeared. Plasma PP did not change. No specific symptoms could be attributed to the new spectrum of peptides found in the tumor. This is the first report of a pancreatic tumor containing high levels of neurostensin.Keywords
This publication has 34 references indexed in Scilit:
- IMMUNOCYTOCHEMICAL DEMONSTRATION OF ENKEPHALIN AND β‐ENDORPHIN IN ENDOCRINE TUMORS OF THE RECTUMActa Pathologica Microbiologica Scandinavica Section A Pathology, 1980
- Vipoma of the pancreas: observations on the diarhrhea and circulatory disturbancesArchives of internal medicine (1960), 1979
- HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOGUE IN NORMAL MANThe Lancet, 1978
- Effects of glucose and arginine on the release of immunoreactive somatostatin from the isolated perfused rat pancreasFEBS Letters, 1978
- Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: Value of measurement in diagnosis and treatmentDigestive Diseases and Sciences, 1978
- Vasoactive Intestinal Peptide and the Watery Diarrhea SyndromeAnnals of Surgery, 1978
- HYPERCALCITONINÆMIA IN VIPOMASThe Lancet, 1978
- Prostaglandins E and F in Endocrine Diarrheagenic SyndromesAnnals of Surgery, 1976
- Inhibition of gastric acid secretion in dogs by neurotensinLife Sciences, 1976
- Hyperglycemia and hyperglucagonemia following neurotensin administrationLife Sciences, 1976